Showing results (1301-1310 of 1,341) with videos related to

Sort By:
Pageof 135
Nature Communications|May 6, 2020
Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infectionEmily Adland, Jane Millar, Nomonde Bengu, et al.
American Journal of Hematology|November 16, 2024
Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapyAintzane Zabaleta, Noemi Puig, Maria-Teresa Cedena, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2015
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1Beatriz Mothe, Nuria Climent, Montserrat Plana, et al.
Journal of Translational Medicine|December 14, 2011
Definition of the viral targets of protective HIV-1-specific T cell responsesBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 6, 2021
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)P Mª Samper Ots, C Vallejo Ocaña, M Martin Martin, et al.
Frontiers in Immunology|May 15, 2026
Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMDMarta Fonseca-Santos, Borja Puertas, Javier Arzuaga-Méndez, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 23, 2025
Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma PatientsIrene Francés Alexandre, Ana Gea Peña, Ana Tobalina García, et al.
Neuro-Oncology|July 1, 2024
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)Iván Márquez-Rodas, Ana Álvarez, Ana Arance, et al.
Nature Medicine|October 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trialJesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Pageof 135